Stay updated with breaking news from Chloe Harman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Supply of most GLP-1 agonists will continue to be constrained until at least the end of 2024 because of increased demand for 'licensed and off-label indications', prescribers have been warned.
NICE has issued final draft guidance recommending empagliflozin as an option for adults with symptomatic chronic heart failure with preserved or mildly reduced ejection fraction.
The British Menopause Society has recommended alternative options for prescribers to consider if Utrogestan (progesterone) is unavailable.
Children with type 2 diabetes are set to benefit from access to two new glucose monitoring technologies that could free them from the burden of fingerprick testing.
Emollient bath additives should not be offered for the management of atopic eczema in children under 12 years, according to updated draft NICE guidance.